Emmis Acquisition Corp. (EMIS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Emmis Acquisition Corp., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$10.31
0.00% today
Market cap
—
Overall quality
59/100
Kronos AI 30-day
−1.3%
0 of 8 simulated paths end higher
Emmis Acquisition Corp. (EMIS) is a Health Care company in Biotechnology: Pharmaceutical Preparations. It trades at $10.31, up 0.00% today, at 122.7 times earnings. Its overall quality score is 59 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is −1.3% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $10.18 (−1.3%) |
| Likely range | −1.6% … −1.1% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 82 |
| Growth | 44 |
| Overall | 59 |
| P/E | 122.7 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.